$Cumberland Pharmaceuticals (CPIX.US)$ VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA Tuesday, 18th February at 7:30 am Vibativ® is a life-saving antibiotic for pneumonia and serious skin infections Approval in China paves the way for launch in world's second-largest market NASHVILLE, Tenn. and SHANGHAI, Feb. 18, 2025 /PRNewswire/ -- Specialty pharmaceutical companies Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) and SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" o...
Cumberland Pharmaceuticals Inc -Vibativ Receives Marketing Approval in China
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA
Tuesday, 18th February at 7:30 am
Vibativ® is a life-saving antibiotic for pneumonia and serious skin infections
Approval in China paves the way for launch in world's second-largest market
NASHVILLE, Tenn. and SHANGHAI, Feb. 18, 2025 /PRNewswire/ -- Specialty pharmaceutical companies Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) and SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" o...
Major Eye Treatment Breakthrough: FDA Reviews New Affordable Eylea Alternative
Major Medical Cannabis Breakthrough: Aurora Unlocks Australia-Wide Patient Access to Top-Ranked Products
Double Dose: Canopy Growth's New Cannabis Beverages Pack Root Beer and Cream Soda with Enhanced THC+CBG
No comment yet